1,004.96
-11.69
(-1.15%)
At close: April 17 at 4:00:02 PM EDT
1,007.50
+2.54
+(0.25%)
After hours: April 17 at 5:29:10 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,872,361
3,872,361
3,788,309
3,919,709
3,717,930
Cost of Revenue
1,546,778
1,546,778
1,547,023
1,611,667
1,546,377
Gross Profit
2,325,583
2,325,583
2,241,286
2,308,042
2,171,553
Operating Expense
1,198,529
1,198,529
1,161,603
1,181,822
1,176,817
Operating Income
1,127,054
1,127,054
1,079,683
1,126,220
994,736
Net Non Operating Interest Income Expense
-74,631
-74,631
-77,366
-55,392
-43,242
Other Income Expense
-15,200
-15,200
-28,589
-236
-2,133
Pretax Income
1,037,223
1,037,223
973,728
1,070,592
949,361
Tax Provision
174,083
174,083
184,950
198,090
180,376
Net Income Common Stockholders
863,140
863,140
788,778
872,502
768,985
Diluted NI Available to Com Stockholders
863,140
863,140
788,778
872,502
768,985
Basic EPS
40.67
--
36.10
38.79
33.25
Diluted EPS
40.48
--
35.90
38.41
32.78
Basic Average Shares
21,221.84
--
21,848.12
22,491.79
23,129.86
Diluted Average Shares
21,320.64
--
21,971.53
22,718.29
23,457.63
Total Expenses
2,745,307
2,745,307
2,708,626
2,793,489
2,723,194
Net Income from Continuing & Discontinued Operation
863,140
863,140
788,778
872,502
768,985
Normalized Income
879,589.47
879,589.47
815,293.35
880,290.14
773,228.59
Interest Expense
74,631
74,631
77,366
55,392
43,242
Net Interest Income
-74,631
-74,631
-77,366
-55,392
-43,242
EBIT
1,111,854
1,111,854
1,051,094
1,125,984
992,603
EBITDA
1,235,075
1,235,075
1,172,258
1,239,007
1,100,660
Reconciled Cost of Revenue
1,496,426
1,496,426
1,498,072
1,564,883
1,501,395
Reconciled Depreciation
123,221
123,221
121,164
113,023
108,057
Net Income from Continuing Operation Net Minority Interest
863,140
863,140
788,778
872,502
768,985
Total Unusual Items Excluding Goodwill
-19,771
-19,771
-32,735
-9,556
-5,239
Total Unusual Items
-19,771
-19,771
-32,735
-9,556
-5,239
Normalized EBITDA
1,254,846
1,254,846
1,204,993
1,248,563
1,105,899
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3,321.53
-3,321.53
-6,219.65
-1,767.86
-995.41
12/31/2021 - 11/14/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WAT Waters Corporation
321.01
-0.03%
IDXX IDEXX Laboratories, Inc.
411.49
+2.26%
IQV IQVIA Holdings Inc.
143.91
-3.05%
MEDP Medpace Holdings, Inc.
296.28
-0.07%
A Agilent Technologies, Inc.
102.48
-0.21%
ICLR ICON Public Limited Company
139.32
-2.94%
LH Labcorp Holdings Inc.
217.12
-1.56%
TMO Thermo Fisher Scientific Inc.
427.50
-2.13%
DGX Quest Diagnostics Incorporated
163.80
-0.41%
DHR Danaher Corporation
186.83
-2.01%